etoposide has been researched along with Ependymoma in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 13 (46.43) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bouffet, E; Chapman, RJ; Dineen, RA; Ellison, DW; Giagnacovo, M; Grundy, RG; Jacques, TS; Jaspan, T; Kilday, JP; Macarthur, D; Mallucci, C; Modena, P; Paine, SML; Pajtler, KW; Ritzmann, TA; Thorp, N | 1 |
| Coyle, B; Grundy, RG; Jackson, HK; Kerr, ID; Kilday, JP; Liu, JF; Sabnis, DH; Storer, LCD | 1 |
| Allen, J; Atlas, M; Dhall, G; Finlay, J; Gardner, S; Garvin, J; Haley, K; Ji, L; Judkins, A; Kennedy, G; Lasky, J; Moertel, C; Moore, T; Olshefski, R; Rassekh, SR; Shore, R; Sposto, R; Tekautz, T; Venkatramani, R; Zhou, S | 1 |
| Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I | 1 |
| Iwafuchi, H; Iwama, J; Kiyotani, C; Matsuoka, K; Morota, N; Ogiwara, H; Terashima, K | 1 |
| Antonelli, M; Balter, R; Barra, S; Bertin, D; Bertolini, P; Biassoni, V; Boschetti, L; Buccoliero, A; Buttarelli, FR; Calareso, G; Cama, A; Cinalli, G; Diletto, B; Ferroli, P; Gandola, L; Garrè, ML; Genitori, L; Giangaspero, F; Giombelli, E; Giussani, C; La Spina, M; Marras, CE; Mascarin, M; Massimino, M; Mastronuzzi, A; Miceli, R; Modena, P; Mussano, A; Pecori, E; Peretta, P; Pollo, B; Quaglietta, L; Sardi, I; Scarzello, G; Schiavello, E; Scoccianti, S; Valentini, L; Viscardi, E | 1 |
| Bouffet, E; Bowers, DC; Foley, MA; Gill, SC; Horan, J; Jakacki, RI; Kieran, MW; Wang, J; Zacharoulis, S | 1 |
| Hattori, Y; Hino, M; Kobayashi, Y; Kurahasi, T; Nakagawa, H; Wada, M | 1 |
| Balter, R; Barra, S; Bertin, D; Biassoni, V; Cama, A; Casali, C; Collini, P; Di Rocco, C; Fidani, P; Gandola, L; Garrè, ML; Genitori, L; Giangaspero, F; Mascarin, M; Massimino, M; Milanaccio, C; Milano, GM; Modena, P; Nozza, P; Peretta, P; Potepan, P; Sardi, I; Scarzello, G; Tamburrini, G; Viscardi, E | 1 |
| Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
| Chamberlain, MC | 3 |
| Balter, R; Barra, S; Brisigotti, M; Burnelli, R; Cama, A; Collini, P; Fidani, P; Forni, M; Gandola, L; Gardiman, M; Garrè, ML; Genitori, L; Giangaspero, F; Madon, E; Mascarin, M; Massimino, M; Navarria, P; Perilongo, G; Podda, M; Pollo, B; Potepan, P; Ricardi, U; Sandri, A; Scarzello, G; Sotti, G; Spreafico, F; Stefanelli, M; Valagussa, P | 1 |
| Basso, ME; Bertin, D; Gandola, L; Genitori, L; Giangaspero, F; Madon, E; Massimino, M; Mastrodicasa, L; Paglino, A; Perilongo, G; Ricardi, U; Sandri, A; Sardi, N; Todisco, L; Valentini, L | 1 |
| Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
| Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
| Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
| Chan, G; Lotocka-Reysner, H; Strahlendorf, C | 1 |
| Donati, PA; Genitori, L; Giordano, F; Mussa, F; Sandri, A; Sanzo, M; Sardi, I | 1 |
| Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y | 1 |
| Chang, TK; Hsien, YL; Hwang, B; Jeng, MJ; Tang, RB; Wong, TT | 1 |
| Bergman, I; Cnaan, A; Garvin, JH; Goldwein, JW; Grass, J; Molloy, P; Needle, MN; Phillips, PC; Sutton, L; Zhao, H | 1 |
| Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S | 1 |
| Chastagner, P; Couanet, D; Doz, F; Edan, C; Frappaz, D; Gambarelli, D; Gentet, JC; Grill, J; Habrand, JL; Kalifa, C; Le Deley, MC; Pierre-Kahn, A; Raquin, MA | 1 |
| Fenton, LZ; Foreman, NK; Madden, JR; Partington, M; Weil, M; Winston, KR | 1 |
| Hirose, T; Komiyama, S; Komuro, Y; Kurahashi, T; Mikami, M; Sakaiya, N; Tei, C | 1 |
| Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD | 1 |
10 trial(s) available for etoposide and Ependymoma
| Article | Year |
|---|---|
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Topics: Child; Chromosome Aberrations; Cyclophosphamide; Ependymoma; Etoposide; Follow-Up Studies; Histones; Humans; Treatment Outcome; Vincristine | 2022 |
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Neurosurgical Procedures; Radiotherapy; Treatment Outcome; Vincristine | 2016 |
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Erlotinib Hydrochloride; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Treatment Outcome; Young Adult | 2016 |
Salvage chemotherapy for recurrent spinal cord ependymona.
Topics: Administration, Oral; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Cord Neoplasms; Thrombocytopenia; Treatment Outcome; Weight Loss | 2002 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Prognosis; Vincristine | 1997 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2001 |
Etoposide for recurrent spinal cord ependymoma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Recurrence, Local; Spinal Cord Neoplasms | 2002 |
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis | 1991 |
18 other study(ies) available for etoposide and Ependymoma
| Article | Year |
|---|---|
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child, Preschool; Drug Resistance, Neoplasm; Drug Synergism; Ependymoma; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Infant; Methotrexate; Neoplasm Invasiveness; Neoplastic Stem Cells; Prognosis; Survival Analysis; Up-Regulation; Vardenafil Dihydrochloride; Verapamil; Vincristine | 2019 |
Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Prognosis; Prospective Studies; Radiotherapy Dosage; Survival Rate; Vincristine | 2013 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome | 2013 |
Neoadjuvant chemotherapy for brain tumors in infants and young children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinoma, Embryonal; Child; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Ependymoma; Etoposide; Female; Glioblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Retrospective Studies; Rhabdoid Tumor; Second-Look Surgery; Treatment Outcome; Vincristine | 2015 |
Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Salvage Therapy; Treatment Outcome; Young Adult | 2016 |
Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Infratentorial Neoplasms; Italy; Male; Methotrexate; Neoplasm, Residual; Supratentorial Neoplasms; Treatment Outcome; Vincristine | 2011 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Ependymoma; Etoposide; Feasibility Studies; Humans; Infratentorial Neoplasms; Patient Compliance; Prospective Studies; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Analysis; Vincristine | 2004 |
Treatment with oral etoposide for childhood recurrent ependymomas.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2005 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Successful peripheral blood stem cell harvest on a 5.5-kg infant.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Volume; Body Weight; Brain Neoplasms; Cisplatin; Citric Acid; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glucose; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heparin; Humans; Infant; Leukapheresis; Peripheral Blood Stem Cell Transplantation | 2006 |
Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain; Brain Neoplasms; Carmustine; Child; Decanoic Acids; Ependymoma; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Polyesters; Radiotherapy; Recurrence | 2008 |
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma | 1995 |
Preirradiation chemotherapy for very young children with brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Ependymoma; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Male; Medulloblastoma; Neurologic Examination; Vinblastine | 1993 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Survival Analysis | 1998 |
Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Ependymoma; Estrogen Receptor Modulators; Etoposide; Female; Humans; Laminectomy; Low Back Pain; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Spinal Cord Neoplasms; Tamoxifen; Treatment Outcome | 2001 |
Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ovarian Neoplasms | 2001 |